Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Chinese Acupuncture & Moxibustion ; (12): 162-164, 2011.
Artículo en Chino | WPRIM | ID: wpr-322627

RESUMEN

The history of collateral puncture therapy in Japan was traced, the current status and characteristics of collateral puncture therapy in Japan were introduced in this paper. Originated in China, the collateral puncture therapy in Japan combined Japanese knowledge of acupuncture with the theory and practice of bloodletting of Portugal Medicine and Netherlands Medicine. The discussion on the theory and technique of the collateral puncture therapy by Kudo Kunsei became the standard of the collateral puncture therapy in Japan in modern times. Based on this discussion, Tetuo Asami proposed a new theory of the collateral puncture therapy which improved the collateral puncture therapy in Japan. Currently, as a part of Japanese health care system, the collateral puncture therapy with Japanese characteristics is gradually accepted by the medical profession in Japan.


Asunto(s)
Humanos , Puntos de Acupuntura , Venodisección , Historia , Métodos , Historia del Siglo XV , Historia del Siglo XVII , Historia del Siglo XVIII , Historia del Siglo XIX , Japón , Medicina Tradicional de Asia Oriental , Meridianos
2.
China Journal of Chinese Materia Medica ; (24): 1346-1348, 2005.
Artículo en Chino | WPRIM | ID: wpr-239681

RESUMEN

<p><b>OBJECTIVE</b>To observe the rate of Zijin powder in inhibiting H22 mice solid and ascites liver cancer and the relation between quatity and effect.</p><p><b>METHOD</b>The Kunming mics, transplanted by H22 liver cells, were divided into a model group, a cyclophosphamide group and three groups of Zijin powder in high dose, medium dose, and low dose. Then observation was made on the rate of Cancer.</p><p><b>RESULT</b>The inhibiting rates of Zijin powder of three groups (high dose group, medium dose group and low dose group) for H22 mice solid liver cancer were 30.8%, 38.31% and 48.59% respectivily. The inhibiting rates of three groups of Zijin powder (low dose group, medium dose and high dose group) for H22 mice ascites liver cancer were 6.77%, 15.59% and 14.90 % respectivily.</p><p><b>CONCLUSION</b>Zijin powder has better effect on H22 mice solid liver cancer, and its effect is greatly increasing with the increased dosage.</p>


Asunto(s)
Animales , Femenino , Humanos , Masculino , Ratones , Antineoplásicos Fitogénicos , Farmacología , Usos Terapéuticos , Relación Dosis-Respuesta a Droga , Medicamentos Herbarios Chinos , Farmacología , Neoplasias Hepáticas , Quimioterapia , Fitoterapia , Polvos , Distribución Aleatoria
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA